Cell Therapeutics of Seattle has agreed to pay a $10.5 million fine to resolve claims that it paid doctors up to $1500 to attend lectures on prescribing Trisenox along with illegal kickbacks to high-volume prescribers of the drug. According to the federal suit, Cell Therapeutics pushed physicians to prescribe the therapy for unauthorized uses, resulting in "tens of thousands" of fraudulent Medicare claims.
- see this release on the settlement
- read the report from The Seattle Times
Cell Therapeutics sells Trisenox. Report
Trisenox demonstrates survival benefits. Report
Cell Therapeutics spins off new protein tech company. Report